TLTimothy Reynold Lim

Timothy Reynold Lim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Timothy Reynold Lim has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Aditya Bharatha

    Division of Neuroradiology, Department of Medical Imaging, Unity Health Toronto–St. Michael’s Hospital, University of Toronto, 30 Bond St, Toronto, ON, Canada M5B 1W8

    4 shared publications
  • Shobhit Mathur

    Departments of Neurosurgery and Medical Imaging, St. Michael’s Hospital, Toronto, Canada

    3 shared publications
  • Suradech Suthiphosuwan

    Department of Medical Imaging, University of Toronto, Toronto, Canada

    3 shared publications
  • Amy Wei Lin

    From the Department of Medical Imaging (V.M., T.R.L., A.W.L., J.K., Y.A.C., A.B., S.M.), St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

    2 shared publications
  • Jiwon Oh

    Division of Neurology, Department of Medicine, St. Michael’s Hospital, The University of Toronto, Toronto, Canada

    2 shared publications
  • Yingming Amy Chen

    From the Department of Medical Imaging (V.M., T.R.L., A.W.L., J.K., Y.A.C., A.B., S.M.), St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

    2 shared publications

Latest Publications

  • Imaging Review and Clinical Manifestations of Lacunar Stroke Syndromes

    by Kevin Ryan T. Yu, Thurl Cledera, Stacey Danica L. Gosiaco, Randall Sidney T. Teh, Jose Victor A. Tamayo, Eazels A. Cadag, Philip Lee S. Chua, Timothy Reynold U. Lim, Maria Lucia Brun-Vergara

    Imaging plays a crucial role in diagnosis of classic and atypical lacunar syndromes, and detection of acute lacunar infarcts can be improved with correlation of clinical and radiologic features.

  • Automated perfusion imaging did not improve reliability of ASPECTS or collateral score in late-window large vessel occlusion stroke

    by Anass Benomar, Robert Fahed, Abdelsimar Tan Omar, Christine Hawkes, Eef J Hendriks, Clare A Enriquez, Muneer Eesa, Grant Stotts, Hubert Lee, Shashank Nagendra, et al.

    Background: The Alberta Stroke Program Early CT Score (ASPECTS) and CT angiography (CTA) Collateral Score (CS) are routinely used to estimate ischemic core burden and collateral status in acute ischemic stroke due to large vessel occlusion, but suffer from limited reliability. Whether automated CT perfusion (CTP) maps improve scoring consistency remains unclear. Objectives: To assess the reliability of these scores on non-contrast computed tomography (NCCT) and CTA among numerous raters, with and without access to automated perfusion maps, and their correlations with endovascular thrombectomy (EVT) decisions. Methods: Twenty-nine clinicians independently rated 60 imaging cases from 30 late-window stroke patients with large vessel occlusion, each presented twice: once using NCCT and CTA alone (‘non-CTP cases’), and once with the addition of perfusion maps (‘CTP cases’). Twenty-eight raters (97%) completed the survey twice. Inter- and intra-reliability was assessed using Gwet’s AC1/2 coefficients (κ G ). Correlations with EVT decisions were evaluated using Cramer V. Results: Inter-rater reliability for ASPECTS was substantial and similar between non-CTP (κ G = 0.65, 95% CI: 0.53 to 0.78) and CTP cases (κ G = 0.64, 95% CI: 0.51 to 0.77). CS showed an almost perfect reliability in both scenarios (κ G = 0.82 and 0.83). Intra-rater agreement was at least substantial. Dichotomizing ASPECTS as 0-2/3-10 improved reliability to almost perfect. ASPECTS strongly correlated with EVT decisions (V=0.80), whereas CS showed moderate correlation (V=0.56), both remaining similar with the addition of CTP (V=0.75 and 0.54, respectively). Conclusion: Automated perfusion imaging did not improve the reliability of ASPECTS or CS. Strong reliability was achieved with NCCT and CTA alone.

  • Conventional and Emerging MRI Biomarkers of Multiple Sclerosis

    by Timothy Reynold Lim, Jerald Garvin Lim, Yusuf Alibrahim, Minth Punpichet, Aditya Bharatha, Erin S. Beck, Martina Absinta, Daniel S. Reich, Jiwon Oh, Suradech Suthiphosuwan

    Emerging MRI biomarkers of multiple sclerosis that directly correlate with underlying pathophysiologic processes hold great promise for improving diagnostic specificity and prognostication.


  • Portable Bedside Low-Field MRI for Assessment of Ventricular Size

    by Vinu Mathew, Timothy Reynold Lim, Akhil Nair, Amy W. Lin, Joel Kosowan, Yingming Amy Chen, Aditya Bharatha, Shobhit Mathur

    BACKGROUND AND PURPOSE: Low-field portable MRI (pMRI) has been shown to be a useful alternative neuroimaging tool in the emergency department (ED) and intensive care unit (ICU), potentially addressing challenges associated with the transport of critically ill patients. We aimed to evaluate the intermodality reliability between low-field pMRI and conventional neuroimaging (CN) for assessment of ventricular size and hydrocephalus. MATERIALS AND METHODS: This retrospective study included all patients who underwent point-of-care 64 mT pMRI at a single tertiary hospital from March 30, 2022 to January 4, 2024, and had a follow-up CN, either CT or MRI, performed within 24 hours of the pMRI scan. Two raters independently evaluated pMRI for presence of hydrocephalus while blinded to CN. Bifrontal diameter, maximum skull, and Evans index were recorded. Interrater and intermodality agreement between pMRI and CN were evaluated by using the intraclass coefficient (ICC) and Cohen κ. RESULTS: Fifty-six patients (mean age of 53.5 [±14.6] years, 61% men) were included in this study. Hydrocephalus was identified in 12 (21%) on pMRI and 13 (23%) on CN. Interrater agreement on pMRI was almost perfect for bifrontal diameter (ICC, 0.94; 95% CI, 0.89–0.97) and Evans index (ICC, 0.92; 95% CI, 0.86–0.95) and substantial for determination of hydrocephalus (κ = 0.72), all P < .01. Intermodality agreement between pMRI and CN was also near perfect for averaged measurements of bifrontal diameter (ICC, 0.94; 95% CI, 0.88–0.97), Evans index (ICC, 0.95; 95% CI, 0.92–0.97), and determination of hydrocephalus (κ = 0.95), all P < .01. Using CN as reference standard, pMRI had sensitivity and specificity of 92% (95% CI, 0.85–0.99) and 100% (95% CI, 1.0–1.0), respectively on qualitative visual assessment, and 80% (95% CI, 0.70–0.90) and 98% (95% CI, 0.94–1.0), respectively, on quantitative assessment by using an Evans index cutoff of 0.3. CONCLUSIONS: Low-field pMRI demonstrated excellent interrater agreement and strong concordance with CN in assessing ventricular size, highlighting its potential as an effective point-of-care tool for neurocritical care applications. Graphical Abstract


  • Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic Neuritis

    by Timothy Reynold Lim, Suradech Suthiphosuwan, Jonathan Micieli, Reza Vosoughi, Raphael Schneider, Amy W. Lin, Yingming Amy Chen, Alexandra Muccilli, James J. Marriott, Daniel Selchen, et al.

    BACKGROUND AND PURPOSE: Low-field 64mT portable brain MRI (pMRI) has recently shown diagnostic promise for MS. This study aimed to evaluate the utility of pMRI in assessing dissemination in space (DIS) in patients presenting with optic neuritis and determine whether deploying pMRI in the MS clinic can shorten the time from symptom onset to MRI. MATERIALS AND METHODS: Newly diagnosed optic neuritis patients referred to a tertiary academic MS center from July 2022 to January 2024 underwent both point-of-care pMRI and subsequent conventional 3T MRI (cMRI). Images were evaluated for periventricular (PV), juxtacortical (JC) and infratentorial (IT) lesions. DIS was determined on brain MRI per 2017 McDonald criteria. Test characteristics were computed using cMRI as the reference. Interrater and intermodality agreement between pMRI and cMRI were evaluated using Cohen’s kappa. Time from symptom onset to pMRI and cMRI during the study period was compared to the preceding 1.5 years before pMRI implementation using Kruskal-Wallis with post-hoc Dunn’s tests. RESULTS: Twenty patients (median age: 32.5 [IQR, 28-40]; 80% females) were included, of whom 9 (45%) and 5 (25%) had DIS on cMRI and pMRI, respectively. Median time interval between pMRI and cMRI was 7 days (IQR, 3.5-12.5). Interrater agreement was very good for PV (95%, κ=0.89), and good for JC and IT lesions (90%, κ=0.69 for both). Intermodality agreement was good for PV (90%, κ=0.80) and JC (85%, κ=0.63), and moderate for IT lesions (75%, κ=0.42) and DIS (80%, κ=0.58). pMRI had a sensitivity of 56% and specificity of 100% for DIS. The median time from symptom onset to pMRI was significantly shorter (8.5 days [IQR 7-12]) compared to the interval to cMRI before pMRI deployment (21 days [IQR 8-49], n=50) and after pMRI deployment (15 days [IQR 12-29], n=30) (both p<0.01). Time from symptom onset to cMRI in those periods was not significantly different (p=0.29). CONCLUSIONS: In optic neuritis patients, pMRI exhibited moderate concordance, moderate sensitivity and high specificity for DIS compared to cMRI. Its integration into the MS clinic reduced the time from symptom onset to MRI. Further studies are warranted to evaluate the role of pMRI in expediting early MS diagnosis and as an imaging tool in resource-limited settings. ABBREVIATIONS: pMRI = portable MRI; cMRI = conventional MRI; pwMS = patients with MS; PV = periventricular; JC= juxtacortical; IT = infratentorial; DIS = dissemination in space


  • Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis

    by Timothy Reynold U Lim, Sunitha P Kumaran, Suradech Suthiphosuwan, Adrian I Espiritu, Ashley Jones, Amy Wei Lin, Jiwon Oh, Aditya Bharatha

    Background: Performing routine brain magnetic resonance imaging (MRI) is widely accepted as the standard of care for disease monitoring in multiple sclerosis (MS), but the utility of performing routine spinal cord (SC) MRI for this purpose is still debatable. Objective: This study aimed to measure the frequency of new isolated cervical spinal cord lesions (CSLs) in people with MS (pwMS) undergoing routine brain and cervical SC-MRI for disease monitoring and determine the factors associated with the development of new CSLs and their prognostic value. Methods: We retrospectively identified 1576 pwMS who underwent follow-up 3T brain and cervical SC-MRI over a 9-month period. MRI was reviewed for the presence of new brain lesions (BLs) and CSLs. Clinical records were reviewed for interval relapses between sequential scans and subsequent clinical relapse and disability worsening after the follow-up MRI. Results: In 1285 pwMS (median interval: 13–14 months) who were clinically stable with respect to relapses, 73 (5.7%) had new CSLs, of which 49 (3.8%) had concomitant new BLs and 24 (1.9%) had new isolated CSLs only. New asymptomatic CSLs were associated with ⩾ 3 prior relapses ( p = 0.04), no disease-modifying therapy (DMT) use ( p = 0.048), and ⩾ 3 new BLs ( p < 0.001); ⩾ 3 new BLs (OR: 7.11, 95% CI: 4.3–11.7, p < 0.001) remained independently associated with new CSLs on multivariable analysis. Having new asymptomatic CSLs was not independently associated with subsequent relapse or disability worsening after the follow-up MRI (median follow-up time of 26 months). Conclusion: Routine brain and cervical SC-MRI detected new isolated CSLs in only < 2% of clinically stable pwMS. Developing new asymptomatic CSLs was associated with concomitant new BLs and did not confer an independent increased risk of relapse or disability worsening. Performing SC-MRI may not be warranted for routine monitoring in most pwMS, and performing only brain MRI may be sufficient to capture the vast majority of clinically silent disease activity.


  • Open Access

    Delayed Gadolinium Leakage in Ocular Structures on Brain MR Imaging: Prevalence and Associated Factors

    by Richard Olatunji, Timothy Reynold Lim, Blair Jones, Monica Tafur, Shobhit Mathur, Amy W. Lin, Aditya Bharatha, Suradech Suthiphosuwan

    BACKGROUND AND PURPOSE: Gadolinium leakage in ocular structures (GLOS) is characterized by hyperintense signal in the chambers of the eye on FLAIR and has been reported in association with blood-ocular barrier breakdown in patients with ischemic strokes. The underlying mechanism of GLOS remains poorly understood; however, some studies suggest it may be part of a physiologic excretion pathway of gadolinium. This study aimed to determine the prevalence of GLOS in an unselected patient population. MATERIALS AND METHODS: A retrospective analysis was conducted on 439 patients who underwent brain MR imaging within 7 days of receiving a gadolinium-based contrast agent injection for a prior MR imaging study. Clinical, imaging, and laboratory data were collected. Descriptive and logistic regression analyses were performed. RESULTS: GLOS was observed in 26 of 439 patients (6%). The occurrence of GLOS varied with time, with 3 (12%), 14 (54%), 8 (31%), and 1 (4%) patient showing GLOS within 24, 25–72, 73–120, and >120 hours after gadolinium-based contrast agent injection, respectively. Patients with GLOS were older (median age: 72 versus 55 years, P = .001) and had higher median serum creatinine levels (73 versus 64 µmol/L, P = .005) and a lower median estimated glomerular filtration rate (84 versus 101 mL/min/1.73 m2, P < .001). A shorter median time interval between gadolinium-based contrast agent injection and the index brain MR imaging was observed in the group positive for GLOS (62 versus 91 hours, P = .003). Multivariable regression analysis identified the estimated glomerular filtration rate (OR = 0.970; 95% CI, 0.049–0.992; P = .008) and time interval since gadolinium-based contrast agent injection (OR = 0.987; 95% CI, 0.977–0.997; P = .012) as independent factors associated with GLOS. CONCLUSIONS: GLOS was observed in only a small percentage of patients receiving gadolinium-based contrast agent within 7 days before brain MR imaging. This phenomenon was noted in patients with normal findings on brain MR imaging and those with various CNS pathologies, and it was associated with lower estimated glomerular filtration rates and shorter time intervals after gadolinium-based contrast agent injection. While GLOS may be a physiologic gadolinium-based contrast agent excretion pathway, the presence of ocular disease was not formally evaluated in the included population. Awareness of GLOS is nonetheless useful for appropriate radiologic interpretation.